recent
ongo
outbreak
viral
pneumonia
spark
worldwid
concern
first
report
decemb
wuhan
spread
rapidli
across
area
caus
major
epidem
confirm
case
includ
death
china
march
novel
highli
infecti
coronaviru
offici
call
sever
acut
respiratori
syndrom
coronaviru
subsequ
identifi
caus
pathogen
outbreak
deep
sequenc
etiolog
investig
global
new
case
spike
countri
apart
china
declar
current
global
public
health
emerg
accord
previou
studi
clinic
characterist
common
symptom
infect
fever
cough
fatigu
short
breath
abnorm
chest
ct
howev
patient
rapidli
develop
sever
pneumonia
symptom
complic
includ
acut
respiratori
distress
syndrom
ard
pulmonari
oedema
acut
kidney
injuri
multipl
organ
failur
case
fatal
rate
around
accord
nation
offici
statist
china
despit
increas
global
threat
host
immun
respons
infect
remain
poorli
understood
viral
rna
recogn
innat
immun
system
three
major
class
cytoplasm
pattern
recognit
receptor
tolllik
receptor
tlr
rigilik
receptor
rlr
nodlik
receptor
nlr
trigger
express
interferon
ifn
activ
antivir
effector
natur
killer
cell
cell
macrophag
coronavirus
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
evolv
strategi
dampen
delay
ifn
product
usual
trigger
exuber
inflammatori
host
respons
lead
sever
lung
patholog
believ
dysregul
host
immun
respons
product
inflammatori
cytokin
known
cytokin
storm
correl
diseas
sever
poor
prognosi
sarscov
merscov
infect
sever
proinflammatori
cytokin
chemokin
rant
aberrantli
elev
merscov
infect
human
peripher
blood
monocytederiv
macrophag
interestingli
recent
studi
report
sever
case
exhibit
increas
plasma
level
gscf
compar
mild
case
indic
inflammatori
cytokin
releas
critic
progress
lymphopenia
common
infect
patient
probabl
due
lymphocyt
induc
apoptosi
furthermor
clinic
patholog
analysi
biopsi
sampl
confirm
interstiti
mononuclear
inflammatori
infiltr
lung
tissu
howev
underli
molecular
mechan
aberr
inflammatori
respons
serolog
histopatholog
infect
still
clear
transcriptom
analys
cell
upon
viru
infect
extrem
use
identifi
host
immun
respons
dynam
gene
regulatori
network
studi
use
rna
sequenc
techniqu
investig
transcript
chang
balf
pbmc
specimen
patient
transcriptom
analys
dataset
identifi
sever
immun
pathway
proinflammatori
cytokin
induc
infect
notabl
balf
areg
pbmc
evidenc
sustain
inflamm
cytokin
storm
patient
kegg
pathway
analysi
pbmc
transcriptom
reveal
patient
lymphopenia
may
caus
activ
apoptosi
signal
pathway
lymphocyt
altogeth
data
suggest
infectioninduc
excess
cytokin
releas
correl
lung
tissu
injuri
pathogenesi
studi
approv
ethic
committe
zhongnan
hospit
wuhan
univers
rnaseq
analys
balf
sampl
pbmc
perform
exist
sampl
collect
standard
diagnost
test
pose
extra
burden
patient
whole
blood
pbmc
ficol
prepar
obtain
patient
healthi
donor
zhongnan
hospit
wuhan
univers
peripher
blood
sampl
ml
patient
healthi
control
drawn
vacutain
tube
ficol
densiti
gradient
centrifug
method
use
separ
pbmc
dilut
blood
phosphatebuff
salin
pb
transfer
ficol
tube
centrifug
min
g
room
temperatur
buffi
coat
pbmc
cell
pool
transfer
falcon
pbmc
wash
twice
ml
pb
centrifug
g
minut
precipit
collect
total
rna
extract
lidocain
inject
segment
lung
local
anesthesia
ml
fraction
room
temperatur
steril
salin
instil
right
middl
lobe
left
lingular
segment
lung
balf
retriev
gentl
syring
suction
put
steril
contain
total
rna
isol
cell
fluid
trizol
trizol
ls
reagent
respect
instruct
manufactur
one
microgram
total
rna
use
input
messeng
rna
purifi
use
oligodt
coval
coupl
magnet
bead
rna
fragment
small
piec
heat
expect
size
nt
nt
firststrand
cdna
synthes
presenc
specif
chemic
ensur
rna
use
templat
doubl
strand
cdna
purifi
agencourt
ampur
xp
bead
reaction
dna
librari
construct
endrepair
adaptorlig
pcr
amplif
intermedi
product
sizeselect
adaptorlig
use
two
round
agencourt
ampur
xp
bead
qualifi
doublestrand
dna
librari
transform
singlestrand
circular
dna
librari
dnadenatur
circular
dna
nanobal
dnb
gener
singlestrand
circular
dna
use
roll
circl
amplif
rca
dnb
qualifi
use
qubit
qualifi
dnb
load
flow
cell
sequenc
platform
mgi
shenzhen
p
r
china
pbmc
sampl
anoth
two
pbmc
healthi
sampl
sequenc
illumina
novaseq
platform
rnaseq
data
balf
healthi
control
sampl
download
ncbi
sra
databas
access
number
rnaseq
read
firstli
map
rrna
sequenc
remov
potenti
rrna
read
use
star
default
paramet
rest
read
map
human
genom
gencod
gene
annot
paramet
follow
guidelin
encod
rnaseq
pipelin
http
githubcomencodedcclongrnaseqpipelin
human
unmapp
read
map
genom
genbank
previous
report
pcr
replic
map
human
genom
remov
picard
markdupl
program
rnaseq
signal
track
gener
use
provid
rseqc
packag
visual
ucsc
genom
browser
custom
track
hub
gene
express
calcul
featurecount
subread
packag
paramet
differenti
express
gene
call
use
packag
follow
criteria
adjust
pvalu
foldchang
express
gene
requir
read
count
greater
balf
pbmc
respect
select
normal
count
per
million
cpm
analysi
function
enrich
analysi
perform
list
differenti
express
gene
use
clusterprofil
packag
v
determin
gene
enrich
specif
term
level
signific
enrich
calcul
hypergeometr
test
term
use
express
gene
background
pvalu
correct
multipl
hypothesi
test
use
benjamini
hochberg
method
control
fals
discoveri
rate
fdr
inspect
gene
specif
goterm
pathway
go
kegg
pathway
annot
download
gene
ontolog
resourc
last
updat
februari
kegg
databas
last
updat
januari
respect
interact
protein
differenti
express
gene
pbmc
balf
identifi
function
human
network
inwebinbipmap
human
interact
network
direct
interact
evid
highconfid
cytoscap
use
visual
ppi
subnetwork
sourc
code
analysi
avail
http
githubcomzhouyulabncov
raw
sequenc
data
studi
deposit
genom
sequenc
archiv
big
data
center
http
bigdbigaccn
beij
institut
genom
big
chines
academi
scienc
access
number
investig
impact
mechan
infect
patient
exploit
rnaseq
detect
transcriptom
chang
pmbc
balf
sampl
healthi
donor
patient
figur
got
sampl
zhongnan
hospit
wuhan
univers
includ
balf
sampl
two
patient
blood
sampl
patient
healthi
individu
data
balf
healthi
sampl
previou
studi
util
ficol
densiti
gradient
centrifug
isol
pbmc
blood
follow
rna
librari
construct
highthroughput
sequenc
perform
qualiti
control
analysi
rnaseq
data
summar
statist
read
map
human
genom
genom
genbank
supplementari
tabl
balf
pbmc
sampl
respect
consist
previou
report
focus
viral
genom
assembl
balf
patient
sampl
contain
high
ratio
viral
read
healthi
control
dataset
zero
count
interestingli
pbmc
sampl
patient
bare
exhibit
viral
read
indic
may
infect
pbmc
data
illustr
high
consist
within
control
patient
group
demonstr
correl
cluster
analysi
balf
pbmc
sampl
respect
supplementari
fig
balf
sampl
detect
express
gene
gene
upregul
gene
decreas
patient
compar
healthi
individu
supplementari
fig
differenti
express
gene
repres
scale
heatmap
compar
patient
healthi
control
balf
figur
b
supplementari
file
pbmc
sampl
figur
c
supplementari
file
pbmc
sampl
found
gene
rna
express
signal
gene
significantli
upregul
gene
downregul
supplementari
fig
interestingli
illustr
rnaseq
signal
shown
genom
browser
decreas
patient
figur
e
express
show
increas
trend
figur
f
although
identifi
significantli
chang
gene
statist
sum
data
provid
global
quantit
resourc
investig
rna
regul
upon
infect
viru
infect
may
induc
dynam
chang
gene
express
specif
cellular
biolog
process
perform
gene
function
enrich
analysi
differenti
regul
gene
balf
pbmc
monitor
chang
cell
patient
healthi
person
balf
sampl
upregul
gene
relat
invas
viru
figur
supplementari
file
viral
infectioninduc
chang
variou
membran
structur
endoplasm
reticulum
inde
enrich
biolog
process
cotransl
protein
target
membran
protein
target
er
viral
transcript
howev
upregul
gene
pbmc
mainli
enrich
complement
activ
humor
immun
respons
mediat
circul
immunoglobulin
b
cell
mediat
immun
figur
b
supplementari
file
indic
activ
immun
activ
pmbc
addit
seri
inflammationrel
process
activ
regul
acut
inflammatori
respons
acut
inflammatori
respons
supplementari
file
interestingli
decreas
gene
balf
patient
enrich
biolog
process
activ
immun
cell
figur
supplementari
file
contrast
decreas
gene
pbmc
patient
involv
biolog
process
axon
guidanc
neuron
project
guidanc
mrnarel
biolog
process
figur
b
supplementari
file
furthermor
kegg
pathway
analysi
perform
downregul
gene
balf
sampl
pathway
enrich
chang
gene
includ
ribosom
protein
process
endoplasm
reticulum
phagosom
pentos
phosphat
pathway
carbon
metabol
lysosom
figur
figur
supplementari
file
file
pbmc
sampl
cell
cycl
metabol
pathway
enrich
upregul
gene
cytokinerel
pathway
enrich
downregul
gene
viral
protein
interact
cytokin
cytokin
receptor
b
signal
pathway
receptor
signal
pathway
signal
pathway
figur
b
supplementari
file
file
interact
protein
differenti
express
gene
balf
pbmc
also
identifi
function
human
network
obtain
global
understand
interact
network
supplementari
fig
accord
previou
clinic
report
patient
cytokin
storm
reminisc
sarscov
infect
identifi
express
cytokin
balf
figur
pbmc
figur
b
significantli
chang
gene
mark
asterisk
clinic
case
high
cytokin
express
observ
balf
agreement
laboratori
find
found
cytokin
highli
express
patient
balf
sampl
comparison
two
patient
indic
express
cytokin
variabl
among
patient
laboratori
find
patient
supplementari
tabl
indic
cell
count
reduct
variou
type
immun
cell
includ
lymphocyt
patient
blood
previou
clinic
autopsi
report
indic
patient
lymphocyt
greatli
reduc
found
sever
significantli
alter
gene
enrich
apoptosi
signal
pathway
figur
includ
ctsl
ctsb
rra
ctsd
ctsz
interestingli
import
gene
process
apoptosi
show
increas
trend
two
patient
indic
pmbc
reduct
may
due
apoptosi
base
differenti
gene
express
analysi
found
signific
differ
level
intracellular
gene
chang
balf
sampl
pbmc
distinct
due
differ
viral
infect
two
type
cell
note
viru
seem
infect
pbmc
fail
detect
viral
rna
well
express
pbmc
supplementari
tabl
also
support
express
data
base
bone
marrowderiv
blood
cell
http
wwwaltanalyzeorg
order
illustr
differ
two
cell
type
classifi
gene
differ
trend
balf
sampl
pbmc
figur
b
gene
chang
direct
gene
opposit
trend
first
analys
gene
increas
pbmc
decreas
blaf
among
gene
gene
particip
small
molecul
catabol
process
pgd
gene
involv
neutrophil
activ
immun
ctsd
gaa
supplementari
file
next
analys
gene
increas
blaf
decreas
pbmc
list
figur
b
although
gene
chang
trend
two
sampl
biolog
mean
still
need
investig
infect
caus
sever
pulmonari
diseas
complic
signific
morbid
mortal
current
optim
treatment
effect
drug
fatal
lung
diseas
understand
host
immun
respons
infect
limit
make
difficult
design
novel
therapeut
viral
infect
usual
caus
massiv
alter
host
transcriptom
lead
aberr
host
cell
metabol
modul
immun
respons
ideal
viral
replic
use
sever
patient
healthi
individu
balf
pbmc
sampl
perform
genomewid
rnasequenc
character
host
immun
respons
patient
found
gene
differenti
express
p
balf
pbmc
sampl
patient
compar
control
respect
expect
gene
fall
categori
includ
humor
immun
respons
lymphocyt
mediat
immun
complement
activ
play
import
role
restrict
viral
infect
inflammatori
respons
viral
pneumonia
doubleedg
sword
although
benefici
inflamm
necessari
local
tissu
fight
infect
exacerb
inflammatori
respons
pneumonia
patient
result
excess
releas
proinflammatori
cytokin
known
cytokin
storm
lead
detriment
outcom
diffus
alveolar
damag
fibrosi
progress
respiratori
failur
multipl
organ
dysfunct
newli
emerg
viru
share
human
receptor
sarscov
viru
one
hallmark
sar
diseas
system
inflamm
cytokin
storm
increas
level
littl
known
immunopatholog
diseas
recent
clinic
investig
reveal
mild
patient
high
level
patient
requir
icu
admiss
higher
level
gcsf
consist
studi
found
express
larg
number
cytokin
significantli
elev
patient
balf
sampl
compar
control
includ
proinflammatori
cytokin
data
suggest
viru
infect
led
cytokin
storm
correl
diseas
sever
increas
transcript
respect
chemokin
receptor
receptor
receptor
also
observ
indic
activ
inflammatori
signal
cytokineschemokin
receptor
play
import
role
cytokin
migrat
activ
immun
cell
site
infect
shown
defici
mice
infect
mouseadapt
sarscov
viru
exhibit
defect
direct
inflammatori
cell
airway
caus
sever
diseas
increas
mortal
addit
result
reveal
high
level
macrophag
chemoattract
neutrophil
chemoattract
facilit
migrat
immun
cell
site
infect
consist
mononuclear
cell
infiltr
lung
tissu
patient
induct
inflammatori
cytokin
tightli
control
prevent
tissu
damag
maintain
proper
immun
homeostasi
shown
proinflammatori
cytokin
requir
regul
inflammatori
respons
bcell
differenti
antibodi
product
increas
sar
patient
laboratori
find
indic
serum
protein
level
increas
patient
supplementari
tabl
howev
transcript
level
significantli
chang
pbmc
figur
supplementari
file
indic
secret
protein
serum
might
lung
epitheli
cell
recent
administr
antibodi
tocilizumab
propos
treatment
clinic
practic
amelior
inflamm
patient
note
notic
rel
lower
express
level
observ
balf
patient
compar
healthi
individu
supplementari
file
signific
differ
pbmc
figur
e
supplementari
file
suggest
axi
cell
balf
pbmc
might
involv
pathophysiolog
diseas
comprehens
clinic
studi
larger
scale
transcriptom
profil
case
need
evalu
justif
mab
treatment
moreov
found
antiinflammatori
cytokin
tgfb
also
induc
upon
viru
infect
resembl
high
tgfb
activ
found
sar
patient
tgfb
multifunct
cytokin
regul
varieti
biolog
process
includ
cell
prolifer
differenti
apoptosi
immun
respons
addit
tgfb
signal
modul
viru
infect
block
cell
apoptosi
promot
fibroblast
prolifer
myofibroblast
differenti
thu
play
critic
role
develop
pulmonari
fibrosi
recent
patient
lung
biopsi
shown
mild
fibrosi
moder
inflamm
data
suggest
increas
express
tgfb
patient
might
caus
pulmonari
fibrosi
lymphopenia
found
larg
portion
sar
patient
although
underli
mechan
remain
unclear
viral
infect
lymphocyt
bare
detect
sar
patient
similarli
observ
viral
gene
express
patient
pbmc
indic
viru
may
infect
lymphocyt
patient
among
patient
autophagi
apoptosi
pathway
highli
express
pbmc
patient
compar
healthi
individu
due
antiinflammatori
effect
glucocorticoid
wide
use
stop
progress
acut
lung
injuri
acut
respiratori
distress
syndrom
sar
patient
suppress
lung
inflamm
howev
glucocorticoid
treatment
critic
signific
side
effect
includ
immunosuppress
impair
antibodi
respons
delay
viral
clearanc
sever
avascular
necrosi
osteoporosi
collect
lymphopenia
sar
patient
like
caus
endogen
exogen
glucocorticoid
ultim
led
apoptosi
lymphocyt
rather
direct
viral
infect
cell
summari
present
work
demonstr
viru
infect
stimul
uniqu
transcriptom
profil
patient
balf
pbmc
addit
cytokin
express
profil
suggest
excess
proinflammatori
cytokin
releas
might
hallmark
patient
furthermor
patient
balf
pbmc
rnaseq
dataset
provid
use
resourc
commun
thorough
analys
yc
kl
yz
conceptu
studi
design
yx
hwj
recruit
patient
collect
specimen
collect
demograph
clinic
data
aj
hw
yql
mz
construct
sequenc
rnaseq
librari
yl
mg
laboratori
test
dw
jy
zt
yz
lc
ms
analys
sequenc
data
lc
yl
yc
interpret
result
yl
lc
wrote
initi
draft
manuscript
yl
yc
yz
kl
revis
manuscript
author
read
approv
final
manuscript
